By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
EWTX insiders were on both sides of the trade this year. Buys came to roughly $199,000 (one buyer), sales to $19.5 million (six sellers).
Fox Jonathan C (Director) made the biggest buy, worth around $199,000.
Zooming out by quarter: 5 quarters in a row of net selling by insiders. Insiders bought in 2 of the last 7 full quarters. On the institutional side, 225 funds reported holding EWTX at the end of Q2 2026, and more funds bought than sold.
Are insiders buying or selling EWTX stock?
In the last 12 months Edgewise Therapeutics, Inc. insiders made open-market purchases worth about $199,000 and sales worth about $19.5 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in EWTX?
The most recent open-market insider trade in EWTX was filed on 2026-08-14.
How many institutions own EWTX?
225 investment managers reported holding EWTX in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded EWTX?
No congressional trades in EWTX were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).